CORPORATEBrazil
Blau Farmacêutica recurring profit falls 5% to R$ 69 million in 3Q26
Blau Farmacêutica posted recurring net income of R$ 69 million in the third quarter of 2026, down 5% in a year, with net revenue of R$ 506 million, up 7%, according to CNN Brasil and Money Times.